Incyte Reports 2017 Fourth-Quarter and Year-End Financial Results, Provides 2018 Financial Guidance and Updates on Key Clinical Programs
Go back to Incyte Reports 2017 Fourth-Quarter and Year-End Financial Results, Provides 2018 Financial Guidance and Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 103.64 -0.02 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.66 | 52 Week High | $118.49 | |||
| Open | $104.61 | 52 Week Low | $55.00 | |||
| Day High | $105.02 | P/E | N/A | |||
| Day Low | $103.07 | EPS | $-0.56 | |||
| Volume | 70,287 | |||||
